iPS Cells iPS cell is an abbreviation of induced pluripotent stem cell, which is an acronym for its English name. Professor Shinya Yamanaka of Kyoto University, who developed this product, was awarded the Nobel Prize in Physiology or Medicine in 2012 based on his results. High hurdles for safety checks Establishment of technology to stably produce high quality cells Development of manufacturing facilities We promotes the idea that individuals, research institutions, health care and commercial industries have by building an integrated platform and generates inexpensive medical iPS cells and accelerates the realization of transplantation medicine for various diseases and other services such as insurance.​

Individuals, research institutions, medical institutions, and other commercial service providers collaborate to develop a platform and an ecosystem where value is shared, centring on iPS Coin. The project aims to realize a future, as soon as possible, where patients with intractable diseases can access transplant treatment using iPS cells. The project also aims to improve the overall medical standard by expediting the broad adoption of regenerative medicine therapies and developing novel treatments.